Ace Health Center, Ltd. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Ace Health Center, Ltd.

Sort by

Viewing results 1‒25 of 98

News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
April 22, 2024
Deepmind Technologies Ltd
DeepMind spin-off aims to halve drug discovery times following Big Pharma deals
...Including clinical trials, it often takes up to a decade to discover and develop a new drug, costing on average about $2.7bn, according to research by the Tufts Center for the Study of Drug Development....
January 10, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
HTSIHow To Give It 2023
The queens of NYC philanthropy
...In October, Tober’s commitment to charity was honoured at New York’s ACE Foundation. “We’ve passed the period of a pretty party....
December 8, 2023
Dementia
US regulators approve first drug to slow progression of Alzheimer’s
...The drug will have a US list price of $26,500 a year, although health insurers will negotiate that down....
July 6, 2023
Pharmaceuticals sector
Drugmaker warns US data rules threaten access to Alzheimer’s treatment
...The company said a decision by Centers for Medicare and Medicaid Services to restrict financial support for Leqembi to Alzheimer’s patients whose doctors participate in a health agency database could have...
June 17, 2023
Dementia
Two Alzheimer’s drugs offer hope to patients after decades of waiting
...The high price of the drugs — lecanemab is priced at $26,500 per year — and tough restrictions imposed by the US government on reimbursement by publicly funded health schemes for amyloid-reducing treatments...
May 8, 2023
FT Live
Funding Biopharma Innovation
Strategies for investing in drug development and commercialization
Wednesday, 26 June345 Park Avenue South, New York, NY, USA
News in-depthLazard Ltd
Peter Orszag: the ‘scholar-banker’ aiming to restore Lazard’s fortunes
...An expert in health insurance markets, he began with life science and healthcare clients....
May 28, 2023
Pharmaceuticals sector
US approves Alzheimer’s drug that slows rate of cognitive decline
...Cheung said Eisai would apply for full approval for Leqembi imminently and talk to the US Centers for Medicare & Medicaid Services about relaxing reimbursement restrictions for the treatment....
January 6, 2023
Pharmaceuticals sector
Swedish scientist behind Alzheimer’s drug has big ambitions
...“Based on these data, we are highly confident in lecanemab’s approval and eventual Centers for Medicare and Medicaid Services (CMS) reimbursement,” he said....
December 2, 2022
Eisai Co Ltd
Japan’s Eisai aims to silence critics over breakthrough Alzheimer’s drug
...One of its biggest setbacks was the disastrous launch of aducanumab, which prompted the US Centers for Medicare & Medicaid Services to severely restrict reimbursement for all amyloid-reducing monoclonal...
November 29, 2022
Travel
Inside New York’s newest — and most expensive — hotel
...But although the acoustic, I was assured, is as good as the one at Jazz at Lincoln Center’s Rose Hall, on a Wednesday in August the atmosphere felt just a little too cool and a far cry from the theatre of...
August 25, 2022
Disease control and prevention
US drugs regulator approves first injectable treatment to prevent HIV
...According to the US Centers for Disease Control and Prevention, in 2020, about a quarter of the 1.2m people for whom PrEP is recommended in the US were prescribed it....
December 21, 2021
News in-depthCovid-19 vaccines
Doubts over efficacy of Chinese vaccines stoke anxiety at home and abroad
...They [the Chinese] took advantage of a tactical window and they’ve pressed other geostrategic priorities — [the acceptance of] Huawei [network technology], Taiwan recognition,” said Daniel Runde, at the Center...
December 7, 2021
News in-depthMikhail Fridman
Mikhail Fridman and Petr Aven: oligarchs caught between Putin and the west
...selling their stake in oil major TNK-BP to state-run giant Rosneft, they built a London-based business empire with holdings from Spain’s Dia supermarket chain and German energy group Wintershall Dea to UK health...
March 4, 2022
Scoreboard
CVC’s win is Real Madrid’s loss Premium content
...Public health permitting, there will be a Super Bowl around the corner, and a football World Cup to round off 2022....
December 18, 2021
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Covid-19 vaccines
China backtracks on comments questioning efficacy of local vaccines
...Gao Fu, head of the Chinese Center for Disease Control and Prevention, told a conference over the weekend that the government was considering mixing vaccines and varying dosing regimens as a way to deal...
April 12, 2021
Covid-19 vaccines
China considers mixing vaccines to bolster efficacy
...However, local health experts have not linked the latest wave to the vaccine’s efficacy rate....
April 11, 2021
Legal services
Top in-house lawyers redefine their role as strategic thinkers
...Over the past year, his role as point of liaison with the White House, the Centers for Disease Control and Prevention, and the Food and Drug Administration allowed CVS Health to become a leading provider...
June 17, 2021
Indonesia
Indonesia relies on vaccine rollout as officials lose ‘control’ of pandemic
...“There’s been an explosion in cases, no serious contact tracing, incredibly high death rates and the hospital system is close to collapsing,” said Evan Laksmana at the Center for Strategic and International...
January 10, 2021
FT WealthNobuko Kobayashi
What next for Japan’s wealthy travellers?
...This is especially true of rich Japanese, as they are generally older than average and so tend to have more pre-existing health problems....
September 1, 2020
Indian politics & policy
Ventilator shortage threatens to cripple India’s coronavirus response
...“Current ICU- and ventilator-equipped bed capacity in India is wholly inadequate to the number of infections at epidemic peak,” said the Center for Disease Dynamics, Economics and Policy in a March 24 report...
April 7, 2020
Coronavirus
US hospitals panic-buy drugs ahead of coronavirus influx
...GSK said it was experiencing increased demand from US health providers for its ventolin inhalers and was looking at contingency plans including increasing production....
March 21, 2020
Alphabet Inc
Alphabet faces investor backlash over human rights policies
...The action, which was co-ordinated by the Investor Alliance for Human Rights, part of the Interfaith Center on Corporate Responsibility, has attracted other co-filers who did not wish to be named....
February 24, 2020
US opioid epidemic
US opioid trial to go ahead after settlement talks fail
...Drug distributor stocks also dropped: Cardinal Health lost 3 per cent to $50.02, McKesson fell 3.1 per cent to $147.56, and AmerisourceBergen was down 1 per cent to $89.64....
October 18, 2019
Special ReportLawyers in a Crisis
FT Global Legal Hackathon gallery: from whistleblower shields to disruptive compliance tools
...Lead organisation/individual: Penn Law Read more: Teamwork helps Zimbabwe pupils shut out of class by Covid-19 Project name: Health Status passport and Exposure alert Description: Health status passport...
August 13, 2020

Previous pagePage 1 of 4Next page